A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Carlos I. Amaya-Chanaga, Michael Y. Choi, Natalie Nguyen, Elizabeth DeVore, Colin MacCarthy, Jacqueline Hilger-Rolfe, Thomas J. Kipps, Januario E. Castro
Institutions: University of California San Diego, Moores Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2731548134